alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting:

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: Topics in Bioengineering.                    

*Date:*                         May 24, 2010.                    

*Time:*                         12 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Joseph D. Mosca, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5158, MSC 7808, Bethesda, MD 20892, (301) 435-2344,                         *moscajos@csr.nih.gov*.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: May 7, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-11515 Filed 5-12-10; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>


<ARTICLE>                       5
<LEGEND>
</LEGEND>
<CIK>                           1010077
<NAME>                          Karts International Incorporated
<MULTIPLIER>                                                      1
<CURRENCY>                                               US Dollars

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                                       DEC-31-2000
<PERIOD-START>                                          JAN-01-2000
<PERIOD-END>                                            DEC-31-2000
<EXCHANGE-RATE>                                                   1
<CASH>                                                       232593
<SECURITIES>                                                      0
<RECEIVABLES>                                               2437540
<ALLOWANCES>                                                  45250
<INVENTORY>                                                 4113038
<CURRENT-ASSETS>                                            7395491
<PP&E>                                                      3270167
<DEPRECIATION>                                               837209
<TOTAL-ASSETS>                                             10138628
<CURRENT-LIABILITIES>                                       4539625
<BONDS>                                                           0
<PREFERRED-MANDATORY>                                             0
<PREFERRED>                                                    5638
<COMMON>                                                       7498
<OTHER-SE>                                                  2815989
<TOTAL-LIABILITY-AND-EQUITY>                               10138628
<SALES>                                                     8854343
<TOTAL-REVENUES>                                            8854343
<CGS>                                                      10918625
<TOTAL-COSTS>                                               3445578
<OTHER-EXPENSES>                                            1260703
<LOSS-PROVISION>                                             109709
<INTEREST-EXPENSE>                                           702907
<INCOME-PRETAX>                                            (6770563)
<INCOME-TAX>                                                  52304
<INCOME-CONTINUING>                                        (6822767)
<DISCONTINUED>                                                    0
<EXTRAORDINARY>                                                   0
<CHANGES>                                                         0
<NET-INCOME>                                               (6822767)
<EPS-BASIC>                                                   (0.98)
<EPS-DILUTED>                                                 (0.98)



</TABLE>
ALD-138 NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS

FOR THE THIRD CIRCUIT

___________

No. 24-1627

___________

IN RE: RANDAL WISE,

Petitioner

____________________________________

On a Petition for Writ of Mandamus from the

United States District Court for the District of New Jersey

(Related to Crim. No. 3-20-cr-00102-001)

____________________________________

Submitted Pursuant to Rule 21, Fed. R. App. P.

June 13, 2024

Before: HARDIMAN, MONTGOMERY-REEVES, and NYGAARD, Circuit Judges

(Opinion filed: June 26, 2024)

_________

OPINION*

_________

PER CURIAM

Randal Wise has filed a petition for a writ of mandamus. For the reasons that 

follow, we will deny the petition.

In January 2020, Wise was indicted in the United States District Court for the 

District of New Jersey on charges of attempting to entice a minor to engage in sexual 

* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not 

constitute binding precedent.
2

activity. In a superseding indictment, charges of transporting child pornography, 

possessing child pornography, and attempting to transfer obscene matter to a minor were

added. In March 2022, Wise was found guilty by a jury on all four counts. He is 

currently awaiting sentencing.

The writ of mandamus will issue only in extraordinary circumstances. See Sporck 

v. Peil, 759 F.2d 312, 314 (3d Cir. 1985). As a precondition to the issuance of the writ, 

Wise must establish that there is no alternative remedy or other adequate means to obtain 

the desired relief and must demonstrate a clear and indisputable right to the relief sought. 

Kerr v. U.S. Dist. Court, 426 U.S. 394, 403 (1976). A petition for a writ of mandamus is 

not a substitute for an appeal. See In re Briscoe, 448 F.3d 201, 212 (3d Cir. 2006). In his 

mandamus petition, Wise asserts that the prosecution and police fabricated evidence 

against him and requests that we dismiss the case against him. Wise has the alternative 

remedy of challenging his conviction in his criminal proceedings and filing an appeal at 

the appropriate time. We note that he has raised similar allegations of fabricated 

evidence in a counseled motion for a new trial filed in the District Court. That motion is 

still pending. Because Wise has alternative remedies, mandamus relief is not warranted.

For the above reasons, we will deny the petition.
##### 



Exhibit 21.1
 SUBSIDIARIES OF THE REGISTRANT
  Name
    
    JurisdictionHLTH Corporation
    
    Delaware225 Summit Associates LLC
    
    New JerseyCLD Corporation
    
    DelawareHealtheon International LLC
    
    DelawareWebMD International, LLC
    
    DelawareWebMD Canada Ventures, Inc.
    
    CanadaWebMD UK Limited
    
    England & WalesHealtheon Software India Private Limited
    
    IndiaHLTH Domain Corporation
    
    DelawarePRX Holdings Corp.
    
    DelawareSNTC Holding, Inc.
    
    DelawarePorex Corporation
    
    DelawarePorex Surgical, Inc.
    
    DelawarePorex Surgical GmbH
    
    GermanyPorex Technologies GmbH
    
    GermanyPorex Technologies LTD
    
    EnglandPorex Technologies SDN.BHD
    
    MalaysiaViPS, Inc.
    
    MarylandViPS BioMedical Services, Inc.
    
    PennsylvaniaSYN Business Holdings, Inc.
    
    CaliforniaSYN Healthcare Service, Inc.
    
    CaliforniaSYNC Corp.
    
    New JerseyWebMD Health
Corp. (approximately 84% owned by HLTH Corporation)
    
    DelawareDE Holdco Inc.
    
    DelawareWebMD, LLC
    
    DelawareEndeavor Technologies, Inc.
    
    GeorgiaHealtheon/WebMD Cable Corporation
    
    DelawareHealtheon/WebMD Internet Corporation
    
    DelawareHW Japan, Inc.
    
    DelawareMDhub, LLC
    
    ConnecticutMedicineNet, Inc.
    
    CaliforniaNational Physicians DataSource, LLC
    
    ConnecticutOnHealth Network Company
    
    WashingtonBabyData.com, Inc.
    
    DelawareDemand Management, Inc.
    
    ColoradoHealth Decisions, Inc.
    
    ColoradoHealth Decisions International, LLC
    
    ColoradoThe Ornish Health Program, Inc.
    
    CaliforniaPhysicians Telephone Directory, Inc.
    
    ConnecticutRxList, Inc.
    
    DelawareRxList LLC
    
    CaliforniaTelemedics, Inc.
    
    GeorgiaWebMD Domain Corp.
    
    DelawareWebMD Health Services Group, Inc.
    
    DelawareSubimo LLC
    
    Delaware




---



##### 



Name
    
    JurisdictionHealthShare Technology, Inc.
    
    DelawareSummex Corporation
    
    IndianaOW Corp.
    
    DelawareMedscape LLC
    
    DelawareConceptis LLC
    
    DelawareMedsite CME LLC
    
    DelawareeMedicine.com LLC
    
    DelawareWebMD International, Inc.
    
    DelawareWebMD Professional Services LLC
    
    DelawareMedsite LLC
    
    Delaware
<PAGE>

                                EXHIBIT 10.14
<PAGE>


                               K2 Design, Inc.
                         30 Broad Street, 16th Floor
                              New York, NY 10280


January 15, 1999

Mr. Douglas Cleek
19 Bedford Road
Mahwah, NJ 07430


                         Re: Extension of Employment

Dear Douglas:

It is my pleasure to let you know that the compensation committee has approved
the following changes to your employment agreement:

1.  The term shall be extended for an additional 3 years terminating on December
    31, 2001.

2.  Effective upon signing your base salary will increase by 20% from the 
    current $127,500.  In addition, on each of January 1, 2000 and 2001 his 
    base salary will be increased by an additional 20%.

3.  You will receive 4 weeks paid vacation annually, and in addition to your
    other benefits, the Company will also continue to pay for the automobile you
    own (approximately $225 per month).

4.  The reference to December 31, 1998 in Section 6 of the Agreement is hereby
    replaced with December 31, 2001.

5.  You will have the right to terminate your employment with the Company upon
    not less than 30 days' prior written notice subsequent to a change in
    control of the Company, in which case your employment thereafter would not
    be restricted by the non-competition provisions of Section 6 of the
    Agreement.

Sincerely,


   Sd/-

Matthew de Ganon
Chairman

Agreed to and accepted:


   Sd/-

Douglas Cleek

Date:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-2792

RICKY L. LEWIS,

Plaintiff - Appellant,

versus

EDMOND J. MATKO, Prosecuting Attorney of Harrison County, and individually; J. W. MCGAHAN,

as police officer for the City of Clarksburg,

WV and individually; THOMAS A. BEDELL, Judge

of Harrison County and parties unknown,

Defendants - Appellees.

Appeal from the United States District Court for the Northern District of West Virginia, at Clarksburg. Irene M. Keeley, District

Judge. (CA-96-200-1)

Submitted: August 14, 1997 Decided: August 20, 1997

Before NIEMEYER, Circuit Judge, and BUTZNER and PHILLIPS, Senior

Circuit Judges.

Dismissed by unpublished per curiam opinion.

Ricky L. Lewis, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant seeks to appeal the district court's order denying

relief on his complaint alleging violations under 42 U.S.C.

§§ 1983-1986 (1994). We have reviewed the record and the district

court's opinion dismissing the action under 28 U.S.C. § 1915(d)

(1994) as frivolous (current version at 28 U.S.C.A. § 1915(e)(2)

(West Supp. 1997)), and find no reversible error. Accordingly, we

deny leave to proceed in forma pauperis and dismiss the appeal on

the reasoning of the district court. Lewis v. Matko, No. CA-96-200-

1 (N.D.W. Va. Nov. 22, 1996). To the extent the order is unclear,

the dismissal is without prejudice. We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the decisional process.

DISMISSED
#### Bertha Braven, as Administratrix, etc., of Harvey Braven, Deceased, Respondent, v. International Railway Company, Appellant.

Judgment and order affirmed, with costs.

All concurred.
<PAGE>

                                                              Exhibit 10 (d) (1)

                               AMENDMENTS TO THE
                          ALCOA EXCESS BENEFITS PLAN C

Pursuant to Article 5 of the Plan, the Plan is amended as follows:

1.   The definition of Annual Compensation is amended by adding the following
     sentence to the end thereof:

          "Special Payments" within the meaning of the Alcoa Deferred
          Compensation Plan are not treated as Annual Compensation.

2.   Section 2.6 is deleted in its entirety and replaced with the following:

          No benefit under this Excess Plan may be assigned, transferred,
          pledged or encumbered or be subject in any manner to alienation or
          anticipation, except that any exceptions to the non-alienation
          provisions in Plan I, shall also apply to benefits hereunder.

3.  In all other respects the Plan is hereby ratified and confirmed.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 13-7674

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

CEDRIC DEON WASHINGTON,

Defendant - Appellant.

Appeal from the United States District Court for the District of 

South Carolina, at Charleston. Patrick Michael Duffy, Senior 

District Judge. (2:09-cr-00800-PMD-4; 2:13-cv-00248-PMD)

Submitted: February 20, 2014 Decided: March 5, 2014

Before GREGORY, FLOYD, and THACKER, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Cedric Deon Washington, Appellant Pro Se. Matthew J. Modica, 

Assistant United States Attorney, Charleston, South Carolina, 

for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Cedric Deon Washington seeks to appeal the district 

court’s order dismissing as untimely his 28 U.S.C. § 2255 (2012)

motion. The order is not appealable unless a circuit justice or 

judge issues a certificate of appealability. 28 U.S.C. 

§ 2253(c)(1)(B) (2012). A certificate of appealability will not 

issue absent “a substantial showing of the denial of a 

constitutional right.” 28 U.S.C. § 2253(c)(2) (2012). When the 

district court denies relief on the merits, a prisoner satisfies 

this standard by demonstrating that reasonable jurists would 

find that the district court’s assessment of the constitutional 

claims is debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 

484 (2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 

(2003). When the district court denies relief on procedural 

grounds, the prisoner must demonstrate both that the dispositive 

procedural ruling is debatable, and that the motion states a 

debatable claim of the denial of a constitutional right. Slack, 

529 U.S. at 484-85. 

We have independently reviewed the record and conclude 

that Washington has not made the requisite showing. 

Accordingly, we deny his motion for a certificate of 

appealability, deny leave to proceed in forma pauperis, and 

dismiss the appeal. We dispense with oral argument because the 

facts and legal contentions are adequately presented in the 
3

materials before this court and argument would not aid the 

decisional process.

DISMISSED
Amendment to Employment Agreement between Saks Incorporated & Stephen I. Sadove



 Exhibit 10.2 
 April 9, 2009 
 Stephen I. Sadove 
 7 Hickory Pine
Court 
 Purchase, NY 10577 
  

	Re:	Employment Agreement between Saks Incorporated and Stephen I. Sadove, dated as of July 31, 2007, as amended on December 16, 2008 (“Employment Agreement”)


 Dear Steve: 
 This letter agreement serves to
amend the Employment Agreement in accordance with Section 13(c) thereof. All capitalized terms in this letter agreement shall have the same meaning as in the Employment Agreement, except as provided herein. 
 Effective June 1, 2009, solely for purposes of Sections 3(a) and 3(b) and the definition of “Good Reason” contained in Section 4(c) of the Employment
Agreement, Executive’s Base Salary shall be reduced 7% from $1,060,000.00 to $985,800. Notwithstanding the preceding sentence, for all other purposes of the Agreement, the term Base Salary shall be $1,060,000.00 (or any higher rate from time to
time in effect). 
 The Company acknowledges that “Good Reason” under the Employment Agreement includes, among other things, “any reduction in
the Executive’s Base Salary [or] annual bonus opportunity in any such case below the level specified by this Agreement without the substitution of an equivalent benefit”, and that the Executive may terminate employment for Good Reason
following the effective date of the change in Base Salary mentioned above. Executive, by signing below, hereby irrevocably waives Executive’s right to claim Good Reason solely as a consequence of the changes provided above. This waiver is a one
time waiver of Executive’s right under the Employment Agreement, and shall not be binding on the Executive in any other respect. 







 The changes to the Employment Agreement described above are subject to the approval of the Human Resources and
Compensation Committee of the Company’s Board of Directors and shall only become effective upon such approval. 
  

	
	Sincerely,
	
	SAKS INCORPORATED
	
	/s/ Christine A. Morena
	Christine A. Morena
	Executive Vice President, Human Resources

  

			
	 By signing on the line below, Executive
 expressly agrees to the change in Base Salary
 and waives Executive’s right to claim “Good
 Reason” under the Employment Agreement

		
	By:	 	/s/ Stephen I. Sadove
		 	Stephen I. Sadove
		
	Title:	 	Chairman and CEO

 Date: 4-12-09 
  

 Page 2
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 2134 Introduced in Senate (IS)]

106th CONGRESS
  2d Session
                                S. 2134

          To temporarily suspend the duty on Solvent Blue 104.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 1, 2000

   Mr. Reed introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To temporarily suspend the duty on Solvent Blue 104.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SOLVENT BLUE 104.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:
      

``    9902.32.72    Solvent Blue 104  Free              No change         No change         On or before 12/
                     (CAS No. 116-75-                                                        31/2004          ''
                     6) (provided                                                                              .
                     for in
                     subheading
                     3204.19.20)....

    (b) Effective Date.--The amendment made by this section shall apply 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
**Exhibit 32.2**

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEYACT OF 2002

 

Inconnection with the Quarterly Report of XETA Technologies, Inc. (the “Company”)on Form 10-Q for the fiscal quarter ended April 30, 2008, as filedwith the Securities and Exchange Commission (the “Report”), I, Robert B.Wagner, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that:

 

(1)                                  TheReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2)                                  Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 
|   | /s/  Robert B. Wagner    |
|--------|--------------------------|
|   | Robert  B. Wagner        |
|   | Chief  Financial Officer |
|   | June 3,  2008       |

 

----